Abnormalities in oxidative metabolism and reductions of thiaminedependent enzymes accompany many age-related neurodegenerative diseases. Thiamine deficiency (TD) produces a cascade of events including mild impairment of oxidative metabolism, activation of microglia, astrocytes and endothelial cells that leads to neuronal loss in select brain regions. The earliest changes occur in a small, well-defined brain region, the submedial thalamic nucleus (SmTN). In the present study, a micropunch technique was used to evaluate quantitatively the selective regional changes in mRNA and protein levels. To test whether this method can distinguish between changes in vulnerable and nonvulnerable regions, markers for neuronal loss (NeuN) and endothelial cells (eNOS) and inflammation (IL-1β, IL-6 and TNF-α) in SmTN and cortex of control and TD mice were assessed. TD significantly reduced NeuN and increased CD11b, GFAP and ICAM-1 immunoreactivity in SmTN as revealed by immunocytochemistry. When assessed on samples obtained by the micropunch method, NeuN protein declined (−49%), while increased mRNA levels were observed for eNOS (3.7-fold), IL-1β (43-fold), IL-6 (44-fold) and TNF-α (64-fold) in SmTN with TD. The only TD-induced change that occurred in cortex with TD was an increase in TNF-α (22-fold) mRNA levels. Immunocytochemical analysis revealed that IL-1β, IL-6 and TNF-α protein levels increased in TD brains and colocalized with glial markers. The consistency of these quantitative results with immunocytochemical measurements validates the micropunch technique. The results demonstrate that TD induces quantitative, distinct inflammatory responses and oxidative stress in vulnerable and non-vulnerable regions that may underlie selective vulnerability.
Introduction
Thiamine deficiency (TD) models the selective neurodegeneration that accompanies mild impairment of oxidative metabolism (Gibson et al., 1999) . Reductions in thiamine-dependent enzymes have been implicated in many neurological disorders including Alzheimer's disease (Gibson et al., 1988; Mastrogiacomo et al., 1993 ), Parkinson's disease (Mizuno et al., 1994) , progressive supranuclear palsy (Albers et al., 2000) , Huntington's disease (Klivenyi et al., 2004 ), Friedreich's ataxia and spinocerebellar ataxia type 1 (Mastrogiacomo et al., 1996) and Wernicke-Korsakoff syndrome (Blass and Gibson, 1977; Butterworth et al., 1993) . Disturbances in thiamine metabolism selectively damage certain brain structures. In humans, TD causes bilateral lesions in the midline, medial and intralaminar nuclei of the thalamus, mammillary bodies, periaqueductal grey, cerebellar vermis and brainstem periventricular regions (Torvik et al., 1982; Victor et al., 1989) .
TD causes a time-dependent, selective neuronal death in specific brain regions, while other cell types are either activated or unaffected (Ke and Gibson, 2004) . Experimental TD in rodents produces bilateral lesions in thalamus and mammillary bodies, including medial dorsal thalamus, anterior medial thalamus, pulvinar thalamus, sparing the other brain regions (Langlais et al., 1996; Ke and Gibson, 2004; Todd and Butterworth, 1998; Troncoso et al., 1981; Watanabe and Kanabe, 1978) . The earliest neuronal death occurs in a small, well-defined brain region, the submedial thalamic nucleus (SmTN) (Calingasan et al., 2000; Ke et al., 2003; Zhang et al., 1995) . The submedial thalamus is also called thalamus submedius or gelatinous nuclei (Franklin and Paxinos, 1997; Paxinos and Watson, 1986) .
Inflammation occurs in many neurodegenerative diseases and possesses unique pathology and symptoms. The pathophysiology of TD-induced damage is unknown, but evidence strongly suggests that oxidative stress and inflammation lead to neuronal loss. Regionally selective neuronal death, activation of other cell types such as astrocytes, microglia and endothelial cells, vascular changes, inflammatory responses and oxidative stress in TD recapitulates many neurodegenerative diseases (Ke and Gibson, 2004) . Our previous studies and those of others show that TD elevates markers of oxidative stress, nitric oxide synthase (NOS), intracellular adhesion molecule-1 (ICAM-1) in early stages and induces 4-hydroxy-2-nonenal (HNE) and hemeoxygenase-1 (HO-1) in late stages (Calingasan et al., 1999; Ke and Gibson, 2004; Kruse et al., 
